BB

Black Bird Biotech IncOOTC BBBT Stock Report

Last reporting period 30 Sep, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

BBBT Stock Analysis

BB

Uncovered

Black Bird Biotech Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-45/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

479.97 B

Black Bird Biotech, Inc. engages in the manufacture and sale of cannabidiol products through its subsidiary, Black Bird Potentials, Inc. Its products include MiteXstream, Grizzly Creek Naturals, and Black Bird American Hemp. The company is headquartered in Argyle, Texas. The company went IPO on 2007-12-10. The firm also manufactures and sells, under its Grizzly Creek Naturals brand name, cannabidiol (CBD) products, including CBD Oils, gummies and pet treats, as well as CBD-infused personal care products. Big Sky American Dist., LLC (Big Sky American) distributes its Grizzly Creek Naturals products, as well as an array of other consumer retail products, in Western Montana. The firm's subsidiaries include Black Bird Potentials Inc. (BB Potentials), Big Sky American and Black Bird Hemp Manager, LLC.

View Section: Eyestock Rating